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It’s now cheaper to print color figures in KI
Have you been concerned in the past about the cost of print-
ing color figures in Kidney International (KI)? KI has listened 
to your concerns and is now offering permanently reduced 
pricing for color figures—a flat fee of $500 per printed page, 
no matter how many color figures are on a page. This pricing 
is more affordable for authors and competitive with other top 
scientific journals. We want to make it easier for authors to 
publish the color figures that demonstrate important scien-
tific findings, and our new pricing reflects our commitment to 
achieving this goal.
nature publishing group
Hepatocyte  
growth factor and 
podocyte injury
Hepatocyte growth factor (HGF) 
induces a variety of effects on many cells 
by binding to its receptor, c-met, includ-
ing the blockade of fibrosis. As they 
report in this issue, Dai et al. generated 
mice that lack c-met in podocytes and 
found that the glomeruli of these mice 
developed normally and that neither 
proteinuria nor any pathologic lesions 
developed as the mice aged. However, 
when adriamycin nephropathy was 
induced, these mice were much worse 
off than the wild-type mice in terms of 
proteinuria and podocyte injury. Treat-
ment of the knockout mice with HGF 
did not improve the glomerulopathy, 
but HGF protected podocytes from 
adriamycin-induced apoptosis in vitro. 
These studies suggest that HGF and 
c-met might have a useful role in pro-
tecting podocytes against various nox-
ious agents. See page 962.
Cost of home 
hemodialysis
Home hemodialysis is a useful adjunct 
to renal replacement therapy and might 
provide longer hours of dialysis. To 
estimate the total cost of home dialysis, 
Komenda et al. estimated the cost of this 
procedure in British Columbia, Canada. 
Most patients performed nocturnal 
hemodialysis. The estimates of hemodi-
alysis were compared between in-center 
dialysis and home dialysis, including 
medications, training, and consumables 
as well as the cost of hospitalization and 
the cost of home remodeling for home 
dialysis. The total cost per patient was 
Can$59,179 for years 2004–2005 and 
Can$48,648 for 2005–2006. The home 
dialysis patients required multiple 
in-center dialysis runs, significantly 
contributing to the overall costs. This 
study highlights the role of hidden costs 
and should help planners and govern-
ment agencies when they design for 
home hemodialysis. See page 1039.
Erythropoietin and 
acute kidney injury
Significant evidence from animal stud-
ies suggests that erythropoietin (EPO) 
might be beneficial in the treatment 
of acute kidney injury (AKI). Endre et 
al. performed a double-blind placebo-
controlled trial to study whether early 
treatment with EPO could prevent the 
development of AKI in patients in an 
intensive care unit. Using biomarkers 
for tubular injury, the authors adminis-
tered EPO when the level of the biomar-
ker increased. This protocol selected 
patients with greater chance of severe 
kidney injury even though the marker-
level elevation was transient. Early 
administration with high-dose EPO 
was safe but did not alter the outcome 
of AKI. See page 1020.
